{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T16:10:08Z","timestamp":1782835808499,"version":"3.54.5"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,2]]},"DOI":"10.1093\/ckj\/sfag021","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:34:50Z","timestamp":1770726890000},"source":"Crossref","is-referenced-by-count":1,"title":["SGLT2 inhibitors and bone health in CKD"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8274-6356","authenticated-orcid":false,"given":"Mathias","family":"Haarhaus","sequence":"first","affiliation":[{"name":"Karolinska University Hospital Karolinska Institutet, Department of Clinical Science, Intervention and Technology, Division of Renal Medicine, , Stockholm ,","place":["Sweden"]},{"name":"Diaverum Sweden , Malm\u00f6 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"2026031808515996800_bib1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41574-020-0392-2","article-title":"Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus","volume":"16","author":"Scheen","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"2026031808515996800_bib2","doi-asserted-by":"publisher","first-page":"e254740","DOI":"10.1001\/jamanetworkopen.2025.4740","article-title":"Balancing efficiency and equity in population-wide CKD screening","volume":"8","author":"Cusick","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026031808515996800_bib3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.kint.2024.11.013","article-title":"Chronic kidney disease-mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"107","author":"Ketteler","year":"2025","journal-title":"Kidney Int"},{"key":"2026031808515996800_bib4","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99123","article-title":"Canagliflozin triggers the FGF23\/1,25-dihydroxyvitamin D\/PTH axis in healthy volunteers in a randomized crossover study","volume":"3","author":"Blau","year":"2018","journal-title":"JCI Insight"},{"key":"2026031808515996800_bib5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12902-024-01575-8","article-title":"Effects of sodium-glucose cotransporter 2 inhibitors on bone metabolism in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Endocr Disord"},{"key":"2026031808515996800_bib6","doi-asserted-by":"publisher","first-page":"112935","DOI":"10.1016\/j.exger.2025.112935","article-title":"SGLT2 inhibitor, bone metabolism biomarkers, and osteoporosis risk: a mendelian randomization study","volume":"211","author":"Wang","year":"2025","journal-title":"Exp Gerontol"},{"key":"2026031808515996800_bib7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1210\/jc.2015-3167","article-title":"Effects of Canagliflozin on fracture risk in patients with type 2 diabetes mellitus","volume":"101","author":"Watts","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026031808515996800_bib8","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/ki.2013.356","article-title":"Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control","volume":"85","author":"Kohan","year":"2014","journal-title":"Kidney Int"},{"key":"2026031808515996800_bib9","doi-asserted-by":"publisher","first-page":"109993","DOI":"10.1016\/j.diabres.2022.109993","article-title":"Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: a population-based cohort study","volume":"190","author":"van Dalem","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"2026031808515996800_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf384","article-title":"Impact of dapagliflozin on bone mineral metabolism in non-diabetic patients with chronic kidney disease: a randomized, double-blind, placebo-controlled study","author":"Elshayeb","year":"2026","journal-title":"Clin Kidney J"},{"key":"2026031808515996800_bib11","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00198-025-07422-3","article-title":"Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)","volume":"36","author":"Bhattoa","year":"2025","journal-title":"Osteoporos Int"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag021\/66852574\/sfag021.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/3\/sfag021\/66852574\/sfag021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/3\/sfag021\/66852574\/sfag021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:55:45Z","timestamp":1773838545000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag021\/8472857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag021","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,2,11]]},"article-number":"sfag021"}}